Nevro is excited to announce that it is now part of Globus Medical, marking an important milestone in its mission to transform chronic pain management through advanced technology and industry-leading clinical evidence. This integration strengthens both companies’ shared commitment to delivering innovative solutions that improve patient outcomes worldwide.
Innovation That Adapts to the Patient Journey
As a Globus Medical company, Nevro continues to advance its flagship technology with the HFX iQ™ SCS system, powered by HFX AdaptivAI™. This system delivers 10 kHz stimulation combined with responsive relief, designed to adapt to the ever-changing needs of patients throughout their treatment journey.
HFX iQ™ offers a long-term treatment option for patients suffering from chronic pain, representing a significant advancement in spinal cord stimulation by enabling more personalized, intelligent therapy.
Commitment to Clinical Evidence and Excellence in Care
Nevro and Globus Medical share a strong commitment to transformative innovation supported by robust clinical evidence. Together, they aim to empower physicians, surgeons, and other healthcare providers with technologies that help deliver better care and improved outcomes for their patients.
This collaboration further strengthens investment in research, development, and medical education, expanding the reach and impact of Nevro’s neuromodulation technologies within the global medical community.
Stronger Together
Becoming part of Globus Medical opens a new chapter for Nevro, enabling greater scale, collaboration, and innovation in chronic pain treatment. By combining expertise, resources, and a shared vision, both organizations are well positioned to continue raising the standard of care.
Together, Nevro and Globus Medical are stronger than ever—focused on advancing medical innovation and improving the lives of patients living with chronic pain.